HIV news from aidsmap.com

Could leronlimab, a CCR5 blocker, be used to facilitate stem-cell transplant cures of HIV?
The 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro last week heard about two more cases of HIV remission in people who had received stem cell transplants for leukaemia. These procedures had also cured their HIV, apparently by replacing all the cells in their body capable of producing HIV with non-infected cells.
>> Read more

Returning to HIV care does not erase the effects of treatment interruption, studies show
People with HIV in South Africa are ten times more likely to develop tuberculosis while interrupting treatment than while taking it, the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro heard last week. Even after resuming treatment and achieving viral suppression, their risk stayed 50% higher.
>> Read more

Enhanced access to diagnostic screening improves care for advanced HIV
Two studies presented at the 26th International AIDS Conference (AIDS 2026) last week show that wider access to diagnostic testing and consistent implementation of screening guidance could each improve the diagnosis of opportunistic infections in people with low CD4 counts. World Health Organization (WHO) guidance recommends that all people with HIV should receive a CD4 cell test at diagnosis or when re-engaging with care after a treatment gap.
>> Read more